The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Officials Examining Horse Deaths at Saratoga
- Stallion Oxbow to Stand at Calumet in 2015
- Competitive Group Entered for Smarty Jones
- California Chrome Progressing Toward PA Derby
- Lemon Drop Kid: A Class Act
- Goldencents vs. Wise Dan Showdown Likely
- Knee Surgery to Sideline Kid Cruz for Year
- Hollendorfer Duo Part of Even Yellow Ribbon
- Micromanage Set for Another Distance Test
- Texas Racing Commission OKs Instant Racing